All articles by Manish Kumar
Manish Kumar
Qi Biodesign completes $75m in total funding to drive genome editing innovations
Qi Biodesign’s plant breeding innovations advance the application of gene editing in agriculture, contributing to food security and sustainable developments
GE HealthCare unveils new advanced deep learning imaging solutions
The new deep learning tools enhance radiology efficiency, improve image quality, reduce scan times, support patient outcomes, and address clinician burnout
LifeSignals wins EU MDR certification for UbiqVue 2A Multiparameter System
The system enables continuous, accurate wireless patient monitoring in home and hospital settings, replacing traditional spot-checks for improved population health management
Scripps Health receives NIH grant to develop smart shoulder replacement implant
Researchers aim to remotely monitor and transmit data from inside a patient’s shoulder after surgery
Tyber Medical achieves Class III MDR CE Mark certification from BSI for PEEK Titanium Plasma-coated cervical cages
Certification Marks Key Milestone in Expanding Global Market Access for Tyber Medical’s Comprehensive Product Portfolio
ESYA Labs, Alamar Biosciences partner to advance biomarker detection
The partnership will leverage Alamar’s NULISA platform and ARGO HT System, which will be available at ESYA Labs’ advanced facility in Dallas, Texas
Zimmer Biomet gets FDA nod for Persona SoluTion PPS Femur
Persona SoluTion PPS Femur is a cementless knee implant with a porous coating and surface treatment, offering an alternative for patients sensitive to bone cement or metal
Next-level efficiency and sustainability: SCHOTT Pharma unveils innovative nest design for ready-to-use cartridges
New diamond-shaped nest design for ready-to-use (RTU) cartridges boosts efficiency in pharmaceutical filling processes by up to 67% and significantly reduces CO2 emissions by close to 25% in the supply chain for 1.5 ml RTU cartridges
Thermo Fisher Scientific launches CTS Detachable Dynabeads CD4 and CTS Detachable Dynabeads CD8 to enhance cell therapy development and production
T cell isolation and controlled release delivers flexibility and control in process development, clinical trials and commercial manufacturing
Haemonetics to divest whole blood assets to GVS for up to $67m
GVS will acquire Haemonetics’ whole blood solutions portfolio, including manufacturing facilities in Covina, California, and Tijuana, Mexico, along with related equipment and assets